WO2025210243 - ANTIVIRAL COMPOUNDS
National phase entry is expected:
Publication Number
WO/2025/210243
Publication Date
09.10.2025
International Application No.
PCT/EP2025/059316
International Filing Date
04.04.2025
Title **
[English]
ANTIVIRAL COMPOUNDS
[French]
COMPOSÉS ANTIVIRAUX
Applicants **
KATHOLIEKE UNIVERSITEIT LEUVEN
Inventors
BARDIOT, Dorothée
CHALTIN, Patrick
JOCHMANS, Dirk
LAPORTE, Manon
LEYSSEN, Pieter
MARCHAND, Arnaud
NEYTS, Johan
Priority Data
24168603.9
04.04.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2405 | |
| EPO | Filing, Examination, Granting | 10193 | |
| Japan | Filing, Examination, Granting | 1846 | |
| South Korea | Filing, Examination, Granting | 1443 | |
| USA | Filing, Examination, Granting | 5190 |
Total:
21,077
Contact Us
Abstract[English]
The present application provides antiviral compounds of formula (1), especially active against coronavirus, as well as pharmaceutical compositions comprising the same. Also provided are methods of use and manufacture of the antiviral compounds and associated compositions.[French]
La présente invention concerne des composés antiviraux de formule (1), particulièrement actifs contre le coronavirus, ainsi que des compositions pharmaceutiques les comprenant. L'invention concerne également des procédés d'utilisation et de fabrication des composés antiviraux et des compositions associées.